Voltral Triple Effect 1.16% Emulgel
A formulation designed for fast absorption6,7
After topical application, diclofenac penetrates through the skin and into the tissues beneath.8 It is retained in the muscle and other tissues that are often the source of pain.8,9
When it comes to topical NSAIDs, formulation can be more important than concentration.10 The Emulgel formulation possesses the advantages of both gels and emulsions, favouring rapid absorption, ease of application and good acceptability to patients.7,11,12
Voltral Triple Effect penetrates through the skin to a depth of up to 1 cm, enabling targeted action against pain and inflammation.4,5
Effective relief of pain and reduction of inflammation1–3
In a randomised, double-blind, placebo-controlled study of patients with acute neck pain, Voltral Triple Effect delivered significantly greater reduction in pain-on-movement and pain-at-rest – over three times that of placebo. Additionally, recovery time was about twice as fast as placebo.1*†
*Recovery time was defined as a clinically relevant decrease in pain plus an increase in neck function.†72 patients with acute neck pain received 2 g Voltral Triple Effect (1.16%) Emulgel four times daily or placebo for 5 days.
The lowest number-needed-to-treat (NNT) vs other topical NSAIDs in acute musculoskeletal pain3,13
A Cochrane Review comparing topical NSAIDs and placebo showed favourable efficacy for Voltral Emulgel*† vs other treatments. Of all topical NSAIDs tested for treatment of acute musculoskeletal pain, Voltral Emulgel had the lowest NNT.3,13‡ with pain relief reported as similar to oral NSAIDs.
This means that for every single patient you treat with Voltral Emulgel over other topical NSAIDs, you have a better chance of giving them the significant pain relief that helps get them back on their feet and enjoying life again.3
*1% and 2% Voltral Emulgel formulations included in the review.†For treatment of strains, sprains or sports or overuse-type injuries.‡vs topical ibuprofen, ketoprofen, benzydamine, piroxicam and indomethacin.
Voltral Emulgel Triple Effect has a reduced systemic side-effect risk15,16
The low systemic absorption of Voltral Emulgel Triple Effect means that it has a reduced risk of systemic side effects.8,15,16*
*There is an increased risk of mild dermatological side effects (e.g. skin irritation) with topical diclofenac, but this is non-serious and reversible.
First-line medication use
To improve pain, inflammation and recovery after sprains and strains, guidance from the National Institute for Health and Care Excellence (NICE) recommends using topical NSAIDs or paracetamol as initial analgesics for soft-tissue injuries.17
Patients should also be advised not to apply heat to the injury during the first 72 hours.17
Bilal wants effective pain relief and fast recovery
Bilal balances the demands of his full-time job with taking care of two young children.
He enjoys going to the gym or exercising outdoors and loves nothing more than playing with his children.
The last thing he needs is pain from a sprain or strain affecting his life.
Voltral Triple Effect speeds recovery by relieving pain and reducing inflammation,1 so Bilal can get back on with his life.
What can Voltral Emulgel Triple Effect do for Hasan?
Hasan wants effective pain relief and fast recovery
Hasan is a senior manager in a large multi-national company with a demanding commute. By the time he has driven 2 hours in each direction, he is usually experiencing pain in his left knee.
On days when his pain is troublesome he needs pain relief that will allow him to get comfortable, so his evening is not disrupted.
Hasan has been seeing a physiotherapist regularly since his youth and prefers using topical treatments. He has recently moved on to using Voltral Emulgel.
Voltral Triple Effect speeds recovery by relieving pain and reducing inflammation,1 so Hasan can get back on with his life.
Recommend Voltral Triple Effect to your patients for reduction of muscle pain and inflammation
Voltral Triple Effect 1.16% Emulgel
For patients who are looking for relief from sprains and strains, using a topical formulation.
1 g of Voltral Triple Effect 1.16% Emulgel contains 11.6 mg of diclofenac diethylamine, which corresponds to 10 mg of diclofenac sodium.
Also contains excipients (carbomer, macrogol cetostearyl ether, Cetiol LC, diethylamine, isopropyl alcohol, propylene glycol, liquid paraffin, perfume cream 45 (containing benzyl benzoate) purified water).
For cutaneous use only. Patients should consult their doctor if the condition does not improve or worsens within 7 days of starting treatment.
The duration of treatment depends on the indication and clinical response. The product should not be used for more than 14 days for soft-tissue injuries or soft-tissue rheumatism, or 21 days for arthritis pain, unless recommended by a doctor.
Adults and adolescents aged 12 and over Voltral Triple Effect 1.16% Emulgel should be applied over the affected area three or four times daily and rubbed gently into the skin. The amount needed depends on the size of the painful area: 2 g to 4 g (cherry to walnut sized) is sufficient to treat an area of about 400–800 cm. After application, the hands should be washed, unless they are the site being treated, and unless the NoMess applicator is used.
Do not apply to cuts, open wounds or any other area where the skin is damaged.
After rubbing the gel into the skin, non-occlusive bandages can be used, however without an airtight dressing.
Allow at least four hours between applications of the gel. Do not apply more than four times in any 24-hour period.
The possibility of experiencing systemic adverse events (those associated with the use of systemic forms of diclofenac) should be considered if topical diclofenac is used at a higher dosage or for a longer period of time than recommended. Topical diclofenac should be applied only to intact, non-diseased skin, and not to skin wounds or open injuries. It should not be allowed to come into contact with the eyes or mucous membranes, and should not be ingested. Discontinue the treatment if a skin rash develops after applying the product.
Topical diclofenac can be used with non-occlusive bandages but should not be used with an airtight occlusive dressing.
Contains propylene glycol esters, which may cause mild, localised skin irritation in some people.
Contains benzyl benzoate which may cause mild, localised skin irritation in some people.
- Known hypersensitivity to diclofenac or to any of the excipients
- Patients in whom asthma, angioedema, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs
- During the last trimester of pregnancy
For the full description of special warnings and precautions with Voltral Triple Effect 1.16% Emulgel, please consult your local Summary of Product Characteristics.
The following convention has been utilised for the classification of undesirable effects: very common (≥ 1/10) common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000):
Infection and infestation Rash pustular Very rare Immune system disorders Angioedema, hypersensitivity (including urticaria) Very rare Respiratory, thoracic and mediastinal disorders Asthma Very rare Skin and subcutaneous tissue disorders Dermatitis (including contact dermatitis), rash, erythema, eczema, pruritus Common Dermatitis bullous Rare Photosensitivity reaction Very rare
For the full list of adverse reactions with Voltral Triple Effect 1.16% Emulgel, please consult your local Summary of Product Characteristics.